Cloetta AB Class B (SE:CLA.B)
:CLA.B
Want to see SE:CLA.B full AI Analyst Report?
Top Page
Cloetta AB
(CLA.B)
Select Model
Select Model
Rating:76Outperform
Price Target:
kr60.00
▲(52.59% Upside)
Action:UpgradedDate:05/09/26
The score is driven primarily by solid financial quality (improving leverage, healthy profitability, consistent free cash flow) and strong technical trend/momentum (price above all key moving averages with positive MACD). The earnings call adds support via strong Q1 execution and reiterated/raised growth and margin ambitions, while the main constraints are only moderate valuation support (P/E ~18, ~2.6% yield) and near-term variability from phasing, FX, and higher planned investment spending.
Positive Factors
Margin Recovery
Sustained adjusted margins above the company’s medium-term target demonstrate improved cost structure and pricing power. Higher operating profit supports durable cash generation, funds reinvestment and dividend policy, and reduces sensitivity to cyclical input-cost swings over the next several years.
Negative Factors
Uneven Top‑Line
Inconsistent revenue growth limits long‑term margin expansion and increases reliance on cost actions to meet targets. Slower or volatile topline makes planning for higher CapEx and dividend commitments riskier and heightens sensitivity to FX and promotional pressure.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Recovery
Sustained adjusted margins above the company’s medium-term target demonstrate improved cost structure and pricing power. Higher operating profit supports durable cash generation, funds reinvestment and dividend policy, and reduces sensitivity to cyclical input-cost swings over the next several years.
Read all positive factors
Cloetta AB (CLA.B) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr15.40B
Dividend Yield2.74%
Average Volume (3M)523.54K
Price to Earnings (P/E)18.0
Beta (1Y)0.28
Revenue Growth0.47%
EPS Growth20.22%
CountrySE
Employees2,559
SectorConsumer Defensive
Sector Strength42
IndustryFood Confectioners
Share Statistics
EPS (TTM)2.63
Shares Outstanding282,884,060
10 Day Avg. Volume306,057
30 Day Avg. Volume523,545
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.02
Price to Sales (P/S)1.35
P/FCF Ratio12.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr59.00Price Target Upside50.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2.62
Revenue Forecast (FY)kr8.69B
Cloetta AB Business Overview & Revenue Model
Company Description
Cloetta AB (publ) operates as a confectionary company. It manufactures and markets chocolate confectionery products, including pralines, chocolate wafers, dragees, plates, and countlines under the Kexchoklad, Polly, Center, Plopp, Tupla, Royal, Sp...
How the Company Makes Money
Cloetta makes money primarily by selling branded confectionery and snack products to customers in the consumer goods supply chain. Its core revenue stream is product sales (e.g., candy, chocolate and other confectionery/snack items) delivered at w...
Cloetta AB Earnings Call Summary
Earnings Call Date:May 06, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 10, 2026
Earnings Call Sentiment Positive
The call conveyed a clearly positive execution narrative: strong volume-driven organic growth, margin expansion (adjusted EBIT above the 2027 target on a Q1 basis), improving leverage (0.6x net debt/EBITDA) and a higher dividend all signal operational and financial momentum. Headwinds include currency translation, one-off compensation items that aided margins, Easter phasing that may temper Q2 comparables, and ongoing geopolitical/price uncertainty. On balance the company demonstrated durable improvements in growth, profitability and balance-sheet strength while acknowledging manageable near-term risks.Positive Updates
Strong Organic Net Sales Growth
Organic net sales grew 6.9% in Q1 2026 (reported growth 3.6% after ~3.3% negative currency translation). Even when adjusting for earlier Easter phasing (SEK 40–45m), organic growth sits at the upper end of the new long-term target range of 3%–4%.
Negative Updates
Dependence on One-Off Compensation for Margin Boost
SEK 44m of supplier compensation was recognized across Q4 2025 (SEK 32m) and Q1 2026 (SEK 12m). Management cautions that some margin improvements were aided by these non-recurring items, so repeatability must be monitored.
Read all updates
Q1-2026 Updates
Positive
Negative
Strong Organic Net Sales Growth
Organic net sales grew 6.9% in Q1 2026 (reported growth 3.6% after ~3.3% negative currency translation). Even when adjusting for earlier Easter phasing (SEK 40–45m), organic growth sits at the upper end of the new long-term target range of 3%–4%.
Read all positive updates
Company Guidance
Management reiterated updated long‑term targets and near‑term expectations: organic growth 3–4% (up from ~1–2%), long‑term adjusted EBIT 14% (with at least 12% by 2027), net debt/EBITDA <1.5% (temporary overshoot allowed for strategic M&A) and a dividend policy targeting ~50% of profit after tax (2025 ordinary dividend SEK 1.40/share = SEK 402m, +27% y/y, paid in April). Q1 2026 metrics underpinning the guidance were: organic net sales +6.9% (reported +3.6% after ~‑3.3% FX), Easter phasing +SEK 40–45m, adjusted operating margin 12.9% (12.4% excl. SEK 12m compensation), pick & mix margin 12% (vs long‑term 7–9%), branded package margin 13.4% (aiming to return to >15% pre‑pandemic), free cash flow SEK 144m, CapEx SEK 38m (planned to rise to 4–5% of sales over 5 years), permanent SG&A savings SEK 60–70m p.a., net debt SEK 820m and leverage 0.6x, and available liquidity just under SEK 3bn; management flagged inflation has stabilised so future growth should be volume‑driven and Q2 will reflect the Easter phasing with H1 expected to be in line with the long‑term growth target.Cloetta AB Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
79
Positive
Cash Flow
71
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.60B | 8.53B | 8.61B | 8.30B | 6.87B | 6.05B |
| Gross Profit | 3.12B | 3.21B | 2.87B | 2.60B | 2.13B | 2.15B |
| EBITDA | 1.29B | 1.42B | 1.14B | 1.05B | 661.00M | 854.00M |
| Net Income | 747.00M | 791.00M | 477.00M | 437.00M | 275.00M | 472.00M |
Balance Sheet | ||||||
| Total Assets | 10.79B | 10.41B | 11.14B | 10.68B | 10.32B | 9.55B |
| Cash, Cash Equivalents and Short-Term Investments | 877.00M | 737.00M | 953.00M | 658.00M | 583.00M | 692.00M |
| Total Debt | 1.63B | 1.60B | 2.51B | 2.48B | 2.48B | 2.37B |
| Total Liabilities | 4.82B | 4.71B | 5.71B | 5.58B | 5.32B | 5.03B |
| Stockholders Equity | 5.97B | 5.71B | 5.43B | 5.10B | 4.99B | 4.51B |
Cash Flow | ||||||
| Free Cash Flow | 869.00M | 924.00M | 602.00M | 496.00M | 305.00M | 664.00M |
| Operating Cash Flow | 1.01B | 1.06B | 765.00M | 778.00M | 519.00M | 858.00M |
| Investing Cash Flow | -137.00M | -131.00M | -91.00M | -280.00M | -213.00M | -191.00M |
| Financing Cash Flow | -1.19B | -1.19B | -367.00M | -379.00M | -406.00M | -436.00M |
Cloetta AB Technical Analysis
Neutral
39.32
Price Trends
51.58
Negative
46.08
Positive
39.87
Positive
Market Momentum
0.30
Positive
41.92
Neutral
5.73
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CLA.B, the sentiment is Neutral. The current price of 39.32 is below the 20-day moving average (MA) of 52.02, below the 50-day MA of 51.58, and below the 200-day MA of 39.87, indicating a neutral trend. The MACD of 0.30 indicates Positive momentum. The RSI at 41.92 is Neutral, neither overbought nor oversold. The STOCH value of 5.73 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:CLA.B.
Cloetta AB Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | kr15.40B | 18.03 | 14.28% | 2.74% | 0.47% | 20.22% | |
69 Neutral | kr1.83B | 5.56 | -0.17% | 2.34% | -3.99% | 123.69% | |
65 Neutral | kr9.60B | 23.89 | ― | 2.56% | 8.70% | 47.82% | |
64 Neutral | kr2.89B | 27.84 | ― | 4.40% | 41.66% | 38.15% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | kr4.11B | 33.11 | 9.34% | 4.83% | -1.56% | 16.94% | |
55 Neutral | kr3.17B | 29.51 | 0.87% | ― | 4.55% | -71.28% |
* Consumer Defensive Sector Average
SE:CLA.B
Cloetta AB
52.25
21.01
67.24%
SE:MSON.B
Midsona AB Class B
12.90
4.35
50.91%
SE:DUNI
Duni AB
87.00
-7.82
-8.25%
SE:HUMBLE
Humble Group AB
7.22
-0.99
-12.06%
SE:VIVA
Viva Wine Group AB
32.00
-8.45
-20.89%
SE:SCST
Scandi Standard AB
146.40
55.06
60.29%
Cloetta AB Corporate Events
Cloetta lifts margins and expands pick & mix as 2026 starts strongly
May 6, 2026
Cloetta AB reported a strong start to 2026, delivering 6.9% organic sales growth in the first quarter, driven by higher volumes in both branded packaged products and pick mix, and helped by an earlier Easter. Net sales rose 3.6% to SEK 2.11 billi...
Cloetta AGM Approves Dividend, Higher Board Fees and New Share-Based Incentive Plan
Apr 21, 2026
Cloetta’s annual general meeting in Stockholm approved the 2025 accounts and confirmed a dividend of SEK 1.40 per share, with a total payout of about SEK 401 million to shareholders. The meeting also discharged the board and CEO from liabili...
Cloetta Calls 2026 AGM and Proposes Higher Dividend, New Incentive Plan
Mar 19, 2026
Cloetta AB has called shareholders to its Annual General Meeting on 21 April 2026 in Stockholm, offering both physical attendance and postal voting options in line with its articles of association. The notice outlines registration requirements, pr...
Cloetta releases 2025 annual and sustainability report
Mar 12, 2026
Cloetta AB has published its 2025 Annual and Sustainability Report, providing a comprehensive overview of its strategy, long-term financial targets, market trends, risks, and corporate governance. The report also details audited financial statemen...
Cloetta Nomination Committee Backs Full Board Re‑election Ahead of 2026 AGM
Feb 20, 2026
Cloetta’s Nomination Committee has proposed that all current board members – Morten Falkenberg, Patrick Bergander, Malin Jennerholm, Pauline Lindwall, Alan McLean Raleigh, Camilla Svenfelt and Mikael Svenfelt – be re-elected at t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.